Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA.

Source:http://linkedlifedata.com/resource/pubmed/id/19995389

Download in:

View as

General Info

PMID
19995389